Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Talampanel in refractory partial seizures
NCT00034814Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Jan 2002
- Primary completion
- Jan 2006
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of talampanel in focal seizures, sponsored by Teva Pharmaceutical Industries Ltd.. Started Jan 2002; status: completed.
02
Drugs
talampanel
03
Conditions
focal seizures
Beyond the preview
Go deeper on NCT00034814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00034814.